Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17336371 [patent_doc_number] => 20220002702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION [patent_app_type] => utility [patent_app_number] => 17/447372 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447372 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/447372
FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION Sep 9, 2021 Abandoned
Array ( [id] => 18717867 [patent_doc_number] => 11795198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof [patent_app_type] => utility [patent_app_number] => 17/465727 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 43 [patent_no_of_words] => 22253 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465727
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof Sep 1, 2021 Issued
Array ( [id] => 17443714 [patent_doc_number] => 20220064219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => Antimicrobial And Antibiofilm Peptides Sequences With Metal-Binding Motifs [patent_app_type] => utility [patent_app_number] => 17/446102 [patent_app_country] => US [patent_app_date] => 2021-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446102 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/446102
Antimicrobial And Antibiofilm Peptides Sequences With Metal-Binding Motifs Aug 25, 2021 Abandoned
Array ( [id] => 18792697 [patent_doc_number] => 11826431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Polypeptide-based ocular absorption enhancer and application thereof [patent_app_type] => utility [patent_app_number] => 17/410174 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 6994 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410174 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410174
Polypeptide-based ocular absorption enhancer and application thereof Aug 23, 2021 Issued
Array ( [id] => 17398281 [patent_doc_number] => 20220040371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/408582 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408582 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/408582
PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE Aug 22, 2021 Pending
Array ( [id] => 18895197 [patent_doc_number] => 20240010682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => HEMOSTATIC ELASTIN-LIKE POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 18/042001 [patent_app_country] => US [patent_app_date] => 2021-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042001 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042001
HEMOSTATIC ELASTIN-LIKE POLYPEPTIDES Aug 16, 2021 Pending
Array ( [id] => 17299488 [patent_doc_number] => 20210395327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => Growth Hormone-Releasing Hormone Antagonists and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/396304 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396304 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/396304
Growth Hormone-Releasing Hormone Antagonists and Uses Thereof Aug 5, 2021 Pending
Array ( [id] => 17399570 [patent_doc_number] => 20220041660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => COMPOSITIONS AND METHODS FOR SEQUESTERING VIRAL PARTICLES IN RESPIRATORY TRACT [patent_app_type] => utility [patent_app_number] => 17/396006 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396006 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/396006
COMPOSITIONS AND METHODS FOR SEQUESTERING VIRAL PARTICLES IN RESPIRATORY TRACT Aug 5, 2021 Abandoned
Array ( [id] => 18620425 [patent_doc_number] => 11753453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Peptide kinase inhibitors and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/394431 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 11593 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394431 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/394431
Peptide kinase inhibitors and methods of use thereof Aug 4, 2021 Issued
Array ( [id] => 17385592 [patent_doc_number] => 20220033444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Cyclic Peptides, Methods of Synthesis, and Methods of Treatment [patent_app_type] => utility [patent_app_number] => 17/390383 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/390383
Cyclic peptides, methods of synthesis, and methods of treatment Jul 29, 2021 Issued
Array ( [id] => 17427000 [patent_doc_number] => 20220054708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => FUNCTIONALIZATION OF PLANT TISSUES FOR HUMAN CELL EXPANSION [patent_app_type] => utility [patent_app_number] => 17/388652 [patent_app_country] => US [patent_app_date] => 2021-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17388652 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/388652
Functionalization of plant tissues for human cell expansion Jul 28, 2021 Issued
Array ( [id] => 18647856 [patent_doc_number] => 20230293632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS [patent_app_type] => utility [patent_app_number] => 18/017669 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9018 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017669 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017669
USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS Jul 25, 2021 Pending
Array ( [id] => 17227269 [patent_doc_number] => 20210353825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => SCALABLE THREE-DIMENSIONAL ELASTIC CONSTRUCT MANUFACTURING [patent_app_type] => utility [patent_app_number] => 17/385862 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385862 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/385862
SCALABLE THREE-DIMENSIONAL ELASTIC CONSTRUCT MANUFACTURING Jul 25, 2021 Abandoned
Array ( [id] => 17657073 [patent_doc_number] => 20220177538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY [patent_app_type] => utility [patent_app_number] => 17/383192 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383192 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/383192
CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY Jul 21, 2021 Abandoned
Array ( [id] => 18345957 [patent_doc_number] => 20230134067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => A PEPTIDE USED FOR IMMUNOTHERAPEUTICS [patent_app_type] => utility [patent_app_number] => 17/639547 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639547 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/639547
A PEPTIDE USED FOR IMMUNOTHERAPEUTICS Jul 20, 2021 Abandoned
Array ( [id] => 17343665 [patent_doc_number] => 20220009996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => CELL SURFACE MODIFICATION BY COATING WITH PEPTIDE AMPHIPHILES (PAS) [patent_app_type] => utility [patent_app_number] => 17/373977 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373977 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/373977
Cell surface modification by coating with peptide amphiphiles (PAs) Jul 12, 2021 Issued
Array ( [id] => 19003605 [patent_doc_number] => 20240067676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => POLYPEPTIDE HAVING ANTI-AGING ACTIVITY, AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/767403 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767403
Polypeptide having anti-aging activity, and application thereof Jul 1, 2021 Issued
Array ( [id] => 17368338 [patent_doc_number] => 20220023390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/365443 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365443 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/365443
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Jun 30, 2021 Abandoned
Array ( [id] => 18649423 [patent_doc_number] => 20230295233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/013344 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013344 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/013344
Polypeptide for repairing mucosal damage or skin wound and use thereof Jun 30, 2021 Issued
Array ( [id] => 18649425 [patent_doc_number] => 20230295235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COMPOUNDS TARGETING ALPHA4-BETA7 INTEGRIN [patent_app_type] => utility [patent_app_number] => 18/011997 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11383 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011997 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011997
COMPOUNDS TARGETING ALPHA4-BETA7 INTEGRIN Jun 24, 2021 Pending
Menu